EMN vs RNTX · P/E 21, rev $9.38B vs $80.6M cap
Eastman Chemical Company (EMN) versus Rein Therapeutics Inc (RNTX) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Latest reported RNTX revenue for 2026-06-30 was $0. Net income was -$12.2M. RNTX currently screens at market cap $80.6M.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. RNTX currently screens at market cap $80.6M.
Not investment advice. Open the EMN and RNTX stock pages for the full models.
Not investment advice.